{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Solanum nigrum L.", "breast cancer", "cell migration", "cytotoxicity", "gene-disease association network", "gene-drug interaction network", "glycolysis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "31835887", "DateRevised": {"Year": "2020", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "12", "Day": "11"}], "Language": ["eng"], "ELocationID": ["112", "10.3390/bioengineering6040112"], "Journal": {"ISSN": "2306-5354", "JournalIssue": {"Volume": "6", "Issue": "4", "PubDate": {"Year": "2019", "Month": "Dec", "Day": "11"}}, "Title": "Bioengineering (Basel, Switzerland)", "ISOAbbreviation": "Bioengineering (Basel)"}, "ArticleTitle": "Probing the Antitumor Mechanism of <i>Solanum nigrum</i> L. Aqueous Extract against Human Breast Cancer MCF7 Cells.", "Abstract": {"AbstractText": ["<i>Solanum nigrum</i> L. is one of the major medicinal plants used to treat cancer. However, the functional mechanism of <i>S. nigrum</i> L. extract is still unknown in spite of numerous studies on its active components. In this study, we probed the potential anticancer mechanism of the aqueous extract of <i>S. nigrum</i> L. (AESN) towards human breast cancer cell line MCF7. At a concentration of 10 g/L, AESN caused 43% cytotoxicity, inhibited the migration, and suppressed the activities of hexokinase and pyruvate kinase by about 30% and 40%, respectively, towards the MCF7 cells. RT<sup>2</sup>-PCR analysis of a panel of 89 caner-related genes identified 13 upregulated and eight downregulated genes (>2-folds) in MCF7 cells upon AESN treatment. Gene ontology (GO) and functional disease ontology (FunDO) analyses show that the antitumor function of <i>S. nigrum</i> L. involves multiple genes and these genes are shared across other diseases or disorders."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada."}], "LastName": "Ling", "ForeName": "Binbing", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada."}], "LastName": "Xiao", "ForeName": "Shujun", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada."}], "LastName": "Yang", "ForeName": "Jinha", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou Province 550025, China."}], "LastName": "Wei", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada."}], "LastName": "Sakharkar", "ForeName": "Meena K", "Initials": "MK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Discovery and Development Research Group, College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada."}], "LastName": "Yang", "ForeName": "Jian", "Initials": "J"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Bioengineering (Basel)", "NlmUniqueID": "101676056", "ISSNLinking": "2306-5354"}, "CoiStatement": "The authors declare there is no conflict of interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Bray F., Ferlay J., Soerjomataram I., Siegel R.L., Torre L.A., Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018;68:394\u2013424. doi: 10.3322/caac.21492.", "ArticleIdList": ["10.3322/caac.21492", "30207593"]}, {"Citation": "Garg A.K., Buchholz T.A., Aggarwal B.B. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid. Redox Signal. 2005;7:1630\u20131647. doi: 10.1089/ars.2005.7.1630.", "ArticleIdList": ["10.1089/ars.2005.7.1630", "16356126"]}, {"Citation": "Konkimalla V.B., Efferth T. Evidence-based Chinese medicine for cancer therapy. J. Ethnopharmacol. 2008;116:207\u2013210. doi: 10.1016/j.jep.2007.12.009.", "ArticleIdList": ["10.1016/j.jep.2007.12.009", "18243610"]}, {"Citation": "Liao G.S., Apaya M.K., Shyur L.F. Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy. Evid. Based Complement. Alternat. Med. 2013;2013:437948. doi: 10.1155/2013/437948.", "ArticleIdList": ["10.1155/2013/437948", "PMC3694462", "23840256"]}, {"Citation": "Li S., Luo X. Compendium of Materia Medica: (Bencao Gangmu) Foreign Languages Press; Beijing, China: 2003."}, {"Citation": "Ling B., Michel D., Sakharkar M.K., Yang J. Evaluating the cytotoxic effects of the water extracts of four anticancer herbs against human malignant melanoma cells. Drug Des. Devel. Ther. 2016;10:3563\u20133572. doi: 10.2147/DDDT.S119214.", "ArticleIdList": ["10.2147/DDDT.S119214", "PMC5098531", "27843296"]}, {"Citation": "Uen W.C., Lee B.H., Shi Y.C., Wu S.C., Tai C.J., Tai C.J. Inhibition of aqueous extracts of Solanum nigrum (AESN) on oral cancer through regulation of mitochondrial fission. J. Tradit. Complement. Med. 2018;8:220\u2013225. doi: 10.1016/j.jtcme.2017.05.011.", "ArticleIdList": ["10.1016/j.jtcme.2017.05.011", "PMC5756017", "29322012"]}, {"Citation": "Huang H.C., Syu K.Y., Lin J.K. Chemical composition of Solanum nigrum linn extract and induction of autophagy by leaf water extract and its major flavonoids in AU565 breast cancer cells. J. Agric. Food Chem. 2010;58:8699\u20138708. doi: 10.1021/jf101003v.", "ArticleIdList": ["10.1021/jf101003v", "20681660"]}, {"Citation": "Li J., Li Q., Feng T., Li K. Aqueous extract of Solanum nigrum inhibit growth of cervical carcinoma (U14) via modulating immune response of tumor bearing mice and inducing apoptosis of tumor cells. Fitoterapia. 2008;79:548\u2013556. doi: 10.1016/j.fitote.2008.06.010.", "ArticleIdList": ["10.1016/j.fitote.2008.06.010", "18687388"]}, {"Citation": "Lin H.M., Tseng H.C., Wang C.J., Chyau C.C., Liao K.K., Peng P.L., Chou F.P. Induction of autophagy and apoptosis by the extract of Solanum nigrum Linn in HepG2 cells. J. Agric. Food Chem. 2007;55:3620\u20133628. doi: 10.1021/jf062406m.", "ArticleIdList": ["10.1021/jf062406m", "17419635"]}, {"Citation": "Tai C.J., Wang C.K., Chang Y.J., Lin C.S., Tai C.J. Aqueous extract of Solanum nigrum leaf activates autophagic cell death and enhances docetaxel-induced cytotoxicity in human endometrial carcinoma cells. Evid. Based Complement. Alternat. Med. 2012;2012:859185. doi: 10.1155/2012/859185.", "ArticleIdList": ["10.1155/2012/859185", "PMC3526186", "23304219"]}, {"Citation": "Tai C.J., Wang C.K., Tai C.J., Lin Y.F., Lin C.S., Jian J.Y., Chang Y.J., Chang C.C. Aqueous extract of Solanum nigrum leaves induces autophagy and enhances cytotoxicity of cisplatin, doxorubicin, docetaxel, and 5-fluorouracil in human colorectal carcinoma cells. Evid. Based Complement. Alternat. Med. 2013;2013:514719.", "ArticleIdList": ["PMC3703357", "23843876"]}, {"Citation": "Fu R., Wang X., Hu Y., Du H., Dong B., Ao S., Zhang L., Sun Z., Zhang L., Lv G., et al. Solamargine inhibits gastric cancer progression by regulating the expression of lncNEAT1_2 via the MAPK signaling pathway. Int. J. Oncol. 2019;54:1545\u20131554. doi: 10.3892/ijo.2019.4744.", "ArticleIdList": ["10.3892/ijo.2019.4744", "PMC6438418", "30864686"]}, {"Citation": "Xie X., Zhang X., Chen J., Tang X., Wang M., Zhang L., Guo Z., Shen W. Fe3O4-solamargine induces apoptosis and inhibits metastasis of pancreatic cancer cells. Int. J. Oncol. 2019;54:905\u2013915. doi: 10.3892/ijo.2018.4637.", "ArticleIdList": ["10.3892/ijo.2018.4637", "PMC6365027", "30483763"]}, {"Citation": "Chen Y., Tang Q., Xiao Q., Yang L., Hann S.S. Targeting EP 4 downstream c-Jun through ERK 1/2-mediated reduction of DNMT 1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells. J. Cell Mol. Med. 2017;21:222\u2013233. doi: 10.1111/jcmm.12958.", "ArticleIdList": ["10.1111/jcmm.12958", "PMC5264151", "27620163"]}, {"Citation": "Al Sinani S.S., Eltayeb E.A., Coomber B.L., Adham S.A. Solamargine triggers cellular necrosis selectively in different types of human melanoma cancer cells through extrinsic lysosomal mitochondrial death pathway. Cancer Cell Int. 2016;16:11. doi: 10.1186/s12935-016-0287-4.", "ArticleIdList": ["10.1186/s12935-016-0287-4", "PMC4756414", "26889092"]}, {"Citation": "Xiang S., Zhang Q., Tang Q., Zheng F., Wu J., Yang L., Hann S.S. Activation of AMPK\u03b1 mediates additive effects of solamargine and metformin on suppressing MUC1 expression in castration-resistant prostate cancer cells. Sci. Rep. 2016;6:36721. doi: 10.1038/srep36721.", "ArticleIdList": ["10.1038/srep36721", "PMC5103223", "27830724"]}, {"Citation": "Sani I.K., Marashi S.H., Kalalinia F. Solamargine inhibits migration and invasion of human hepatocellular carcinoma cells through down-regulation of matrix metalloproteinases 2 and 9 expression and activity. Toxicol. In Vitro. 2015;29:893\u2013900. doi: 10.1016/j.tiv.2015.03.012.", "ArticleIdList": ["10.1016/j.tiv.2015.03.012", "25819016"]}, {"Citation": "Zhang X., Yan Z., Xu T., An Z., Chen W., Wang X., Huang M., Zhu F. Solamargine derived from Solanum nigrum induces apoptosis of human cholangiocarcinoma QBC939 cells. Oncol. Lett. 2018;15:6329\u20136335.", "ArticleIdList": ["PMC5920861", "29731848"]}, {"Citation": "Wang H.C., Wu D.H., Chang Y.C., Li Y.J., Wang C.J. Solanum nigrum Linn. water extract inhibits metastasis in mouse melanoma cells in vitro and in vivo. J. Agric. Food Chem. 2010;58:11913\u201311923. doi: 10.1021/jf1022065.", "ArticleIdList": ["10.1021/jf1022065", "21028816"]}, {"Citation": "Zhao Z., Jia Q., Wu M.S., Xie X., Wang Y., Song G., Zou C.Y., Tang Q., Lu J., Huang G., et al. Degalactotigonin, a Natural Compound from Solanum nigrum L., Inhibits Growth and Metastasis of Osteosarcoma through GSK3beta Inactivation-Mediated Repression of the Hedgehog/Gli1 Pathway. Clin. Cancer Res. 2018;24:130\u2013144. doi: 10.1158/1078-0432.CCR-17-0692.", "ArticleIdList": ["10.1158/1078-0432.CCR-17-0692", "28951519"]}, {"Citation": "Lai Y.J., Tai C.J., Wang C.W., Choong C.Y., Lee B.H., Shi Y.C., Tai C.J. Anti-Cancer Activity of Solanum nigrum (AESN) through Suppression of Mitochondrial Function and Epithelial-Mesenchymal Transition (EMT) in Breast Cancer Cells. Molecules. 2016;21:553. doi: 10.3390/molecules21050553.", "ArticleIdList": ["10.3390/molecules21050553", "PMC6274361", "27136519"]}, {"Citation": "Son Y.O., Kim J., Lim J.C., Chung Y., Chung G.H., Lee J.C. Ripe fruit of Solanum nigrum L. inhibits cell growth and induces apoptosis in MCF-7 cells. Food Chem. Toxicol. 2003;41:1421\u20131428. doi: 10.1016/S0278-6915(03)00161-3.", "ArticleIdList": ["10.1016/S0278-6915(03)00161-3", "12909277"]}, {"Citation": "Heo K.S., Lee S.J., Ko J.H., Lim K., Lim K.T. Glycoprotein isolated from Solanum nigrum L. inhibits the DNA-binding activities of NF-kappaB and AP-1, and increases the production of nitric oxide in TPA-stimulated MCF-7 cells. Toxicol. In Vitro. 2004;18:755\u2013763. doi: 10.1016/j.tiv.2004.03.003.", "ArticleIdList": ["10.1016/j.tiv.2004.03.003", "15465640"]}, {"Citation": "Tuan Anh H.L., Tran P.T., Thao D.T., Trang D.T., Dang N.H., Van Cuong P., Kiem P.V., Minh C.V., Lee J.H. Degalactotigonin, a Steroidal Glycoside from Solanum nigrum, Induces Apoptosis and Cell Cycle Arrest via Inhibiting the EGFR Signaling Pathways in Pancreatic Cancer Cells. BioMed Res. Int. 2018;2018:3120972. doi: 10.1155/2018/3120972.", "ArticleIdList": ["10.1155/2018/3120972", "PMC6311251", "30643798"]}, {"Citation": "Shen K.H., Liao A.C., Hung J.H., Lee W.J., Hu K.C., Lin P.T., Liao R.F., Chen P.S. \u03b1-Solanine inhibits invasion of human prostate cancer cell by suppressing epithelial-mesenchymal transition and MMPs expression. Molecules. 2014;19:11896\u201311914. doi: 10.3390/molecules190811896.", "ArticleIdList": ["10.3390/molecules190811896", "PMC6271914", "25116803"]}, {"Citation": "Weihua Z., Saji S., Makinen S., Cheng G., Jensen E.V., Warner M., Gustafsson J.A. Estrogen receptor (ER) beta, a modulator of ERalpha in the uterus. Proc. Natl. Acad. Sci. USA. 2000;97:5936\u20135941. doi: 10.1073/pnas.97.11.5936.", "ArticleIdList": ["10.1073/pnas.97.11.5936", "PMC18537", "10823946"]}, {"Citation": "Christie E.L., Pattnaik S., Beach J., Copeland A., Rashoo N., Fereday S., Hendley J., Alsop K., Brady S.L., Lamb G., et al. Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer. Nat. Commun. 2019;10:1295. doi: 10.1038/s41467-019-09312-9.", "ArticleIdList": ["10.1038/s41467-019-09312-9", "PMC6426934", "30894541"]}, {"Citation": "Gilroy D.W., Colville-Nash P.R. New insights into the role of COX 2 in inflammation. J. Mol. Med. (BERL) 2000;78:121\u2013129. doi: 10.1007/s001090000094.", "ArticleIdList": ["10.1007/s001090000094", "10868474"]}, {"Citation": "Goos J.A., Hiemstra A.C., Coupe V.M., Diosdado B., Kooijman W., Delis-Van Diemen P.M., Karga C., Belien J.A., Menke-van der Houven van Oordt C.W., Geldof A.A., et al. PET group. Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases. Br. J. Cancer. 2014;111:749\u2013755. doi: 10.1038/bjc.2014.354.", "ArticleIdList": ["10.1038/bjc.2014.354", "PMC4134500", "24983372"]}, {"Citation": "Kuwano T., Nakao S., Yamamoto H., Tsuneyoshi M., Yamamoto T., Kuwano M., Ono M. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J. 2004;18:300\u2013310. doi: 10.1096/fj.03-0473com.", "ArticleIdList": ["10.1096/fj.03-0473com", "14769824"]}, {"Citation": "Zaidi S.K., Hoda M.N., Tabrez S., Ansari S.A., Jafri M.A., Shahnawaz Khan M., Hasan S., Alqahtani M.H., Mohammed Abuzenadah A., Banu N. Protective Effect of Solanum nigrum Leaves Extract on Immobilization Stress Induced Changes in Rat\u2019s Brain. Evid. Based Complement. Alternat. Med. 2014;2014:912450. doi: 10.1155/2014/912450.", "ArticleIdList": ["10.1155/2014/912450", "PMC3934381", "24665335"]}, {"Citation": "Eckel R.H., Kahn S.E., Ferrannini E., Goldfine A.B., Nathan D.M., Schwartz M.W., Smith R.J., Smith S.R. Obesity and type 2 diabetes: What can be unified and what needs to be individualized? J. Clin. Endocrinol. Metab. 2011;96:1654\u20131663. doi: 10.1210/jc.2011-0585.", "ArticleIdList": ["10.1210/jc.2011-0585", "PMC3206399", "21602457"]}, {"Citation": "Twig G., Afek A., Derazne E., Tzur D., Cukierman-Yaffe T., Gerstein H.C., Tirosh A. Diabetes risk among overweight and obese metabolically healthy young adults. Diabetes Care. 2014;37:2989\u20132995. doi: 10.2337/dc14-0869.", "ArticleIdList": ["10.2337/dc14-0869", "25139886"]}, {"Citation": "Rugo H., Shtivelman E., Perez A., Vogel C., Franco S., Tan Chiu E., Melisko M., Tagliaferri M., Cohen I., Shoemaker M., et al. Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer. Breast Cancer Res. Treat. 2007;105:17\u201328. doi: 10.1007/s10549-006-9430-6.", "ArticleIdList": ["10.1007/s10549-006-9430-6", "17111207"]}, {"Citation": "Perez A.T., Arun B., Tripathy D., Tagliaferri M.A., Shaw H.S., Kimmick G.G., Cohen I., Shtivelman E., Caygill K.A., Grady D., et al. A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer. Breast Cancer Res. Treat. 2010;120:111\u2013118. doi: 10.1007/s10549-009-0678-5.", "ArticleIdList": ["10.1007/s10549-009-0678-5", "20054647"]}, {"Citation": "Salmenper\u00e4 L., Suominen T., Vertio H. Physicians\u2019 attitudes towards the use of complementary therapies (CTs) by cancer patients in Finland. Eur. J. Cancer Care (Engl.) 2003;12:358\u2013364. doi: 10.1046/j.1365-2354.2003.00440.x.", "ArticleIdList": ["10.1046/j.1365-2354.2003.00440.x", "14982315"]}, {"Citation": "Mohd Mujar N.M., Dahlui M., Emran N.A., Abdul Hadi I., Wai Y.Y., Arulanantham S., Hooi C.C., Mohd Taib N.A. Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia. PLoS ONE. 2017;12:e0176394. doi: 10.1371/journal.pone.0176394.", "ArticleIdList": ["10.1371/journal.pone.0176394", "PMC5407802", "28448541"]}, {"Citation": "Johnson S.B., Park H.S., Gross C.P., Yu J.B. Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival among Patients with Curable Cancers. JAMA Oncol. 2018;4:1375\u20131381. doi: 10.1001/jamaoncol.2018.2487.", "ArticleIdList": ["10.1001/jamaoncol.2018.2487", "PMC6233773", "30027204"]}]}], "History": [{"Year": "2019", "Month": "11", "Day": "22"}, {"Year": "2019", "Month": "12", "Day": "6"}, {"Year": "2019", "Month": "12", "Day": "9"}, {"Year": "2019", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "15", "Hour": "6", "Minute": "1"}, {"Year": "2019", "Month": "12", "Day": "11"}], "PublicationStatus": "epublish", "ArticleIdList": ["31835887", "PMC6955812", "10.3390/bioengineering6040112", "bioengineering6040112"]}}]}